Gender Hyperandrogenism
Item
hyperandrogenic women who were classified into four groups:
boolean
C0079399 (UMLS CUI [1,1])
C0206081 (UMLS CUI [1,2])
Total Testosterone Measurement
Item
total testosterone (tt),
boolean
C0202227 (UMLS CUI [1])
Androstenedione
Item
androstenedione (a4),
boolean
C0002860 (UMLS CUI [1])
FAI - Free androgen index measurement
Item
free androgen index (fai),
boolean
C0428629 (UMLS CUI [1])
Dehydroepiandrosterone Sulfate
Item
and dehydroepiandrosterone sulphate(dhea-s).
boolean
C0057277 (UMLS CUI [1])
Increased androgen level | Androgen level Cutoff Value | Gender Without Hyperandrogenism
Item
according to abnormally elevated androgen measures each above its cut-off value, and non hyperandrogenic women (who had all androgens below their cut-off values)
boolean
C1295651 (UMLS CUI [1])
C0919646 (UMLS CUI [2,1])
C1442160 (UMLS CUI [2,2])
C1522609 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C0206081 (UMLS CUI [3,3])
Exclusion Criteria Fulfill
Item
none of the women studied had
boolean
C0680251 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Hypogonadotropic hypogonadism
Item
hypogonadotropic hypogondism,
boolean
C0271623 (UMLS CUI [1])
Hyperprolactinemia
Item
hyperprolactinemia,
boolean
C0020514 (UMLS CUI [1])
Congenital adrenal hyperplasia
Item
congenital adrenal hyperplasia,
boolean
C0001627 (UMLS CUI [1])
Premature Menopause
Item
premature ovarian failure,
boolean
C0025322 (UMLS CUI [1])
Tumors Androgen secretion
Item
androgen-secreting tumors,
boolean
C0027651 (UMLS CUI [1,1])
C3271399 (UMLS CUI [1,2])
Cushing Syndrome
Item
cushing's syndrome,
boolean
C0010481 (UMLS CUI [1])
Endocrine System Disease Affecting Reproductive function | Systemic disease Affecting Reproductive function
Item
or any other endocrine or systemic disease that may affect the reproductive function,
boolean
C0014130 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0232896 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0232896 (UMLS CUI [2,3])
Uterine Diseases | Asherman Syndrome | Mullerian agenesis | Congenital chromosomal disease | Turner Syndrome
Item
or any disorders of the uterus (e.g. asherman's syndrome and mullerian genesis) and chromosomal anomalies (e.g. turner's syndrome).
boolean
C0042131 (UMLS CUI [1])
C0156372 (UMLS CUI [2])
C4230168 (UMLS CUI [3])
C0008626 (UMLS CUI [4])
C0041408 (UMLS CUI [5])
Exclusion Criteria Additional
Item
in addition, we excluded females who had
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Menarche Recent
Item
experienced menarche less than three years preceding the study start,
boolean
C0025274 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Follicle stimulating hormone measurement | Gender Medical Records Insufficient
Item
or who had day 3 fsh > 15 miu/ml, as well as women with insufficient clinical/biochemical records,
boolean
C0202022 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0025102 (UMLS CUI [2,2])
C0231180 (UMLS CUI [2,3])
Ovarian Cysts Ultrasonography | Ovarian neoplasm Ultrasonography
Item
and women with ovarian cysts or tumors in an ultrasonographic examination.
boolean
C0029927 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C0919267 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])